KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $79.0 million.

  • Xylem's Capital Expenditures rose 675.68% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.0 million, marking a year-over-year increase of 1047.62%. This contributed to the annual value of $321.0 million for FY2024, which is 1845.02% up from last year.
  • Latest data reveals that Xylem reported Capital Expenditures of $79.0 million as of Q3 2025, which was up 675.68% from $98.0 million recorded in Q2 2025.
  • In the past 5 years, Xylem's Capital Expenditures ranged from a high of $100.0 million in Q4 2024 and a low of $39.0 million during Q1 2021
  • Its 5-year average for Capital Expenditures is $66.1 million, with a median of $71.0 million in 2025.
  • As far as peak fluctuations go, Xylem's Capital Expenditures soared by 7234.04% in 2021, and later crashed by 2592.59% in 2022.
  • Xylem's Capital Expenditures (Quarter) stood at $81.0 million in 2021, then dropped by 25.93% to $60.0 million in 2022, then skyrocketed by 56.67% to $94.0 million in 2023, then increased by 6.38% to $100.0 million in 2024, then decreased by 21.0% to $79.0 million in 2025.
  • Its Capital Expenditures stands at $79.0 million for Q3 2025, versus $98.0 million for Q2 2025 and $71.0 million for Q1 2025.